MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF

A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecologica...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TERRACOL DIDIER, GICQUEL JENNIFER, SAMOYEAU ROLAND
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecological; Osteopathic; Cytostatic; Anticonvulsant. No biological data given. MECHANISM OF ACTION : None given.